(Q44616100)

4 December 2017

title

Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis (English)

1 reference

experimental autoimmune encephalomyelitis

4 December 2017

0 references

0 references

author name string

Yossi Gilgun-Sherki

1

1 reference

4 December 2017

Hana Panet

2

1 reference

4 December 2017

Eldad Melamed

3

1 reference

4 December 2017

Daniel Offen

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

7 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14556941

full work available at URL

21 March 2024

https://api.elsevier.com/content/article/PII:S0006899303033432?httpAccept=text/xml

1 reference

10.1016/S0006-8993(03)03343-2

DOI

https://api.crossref.org/works/10.1016/S0006-8993(03)03343-2

https://api.elsevier.com/content/article/PII:S0006899303033432?httpAccept=text/plain

21 March 2024

1 reference

10.1016/S0006-8993(03)03343-2

DOI

https://api.crossref.org/works/10.1016/S0006-8993(03)03343-2

21 March 2024

1 reference

4 December 2017

volume

989

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

196-204

1 reference

Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Changes in neurotransmitters in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

The management of multiple sclerosis patients

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Axonal damage in acute multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Effects of riluzole on electrically evoked neurotransmitter release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole blocks dopamine release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Glutamate excitotoxicity in a model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Assessment of animal models for MS and demyelinating disease in the design of rational therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Neurotransmitters in cerebrospinal fluid reflect pathological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole inhibits the persistent sodium current in mammalian CNS neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Effect of riluzole on focal cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

Kainate-induced currents in rat cortical neurons in culture are modulated by riluzole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2903343-2

10.1016/S0006-8993(03)03343-2

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference